"Will to Live tells how Brazil, against all odds, became the first developing country to universalize access to life saving AIDS therapies - a breakthrough made possible by an unexpected alliance of activists, government reformers, development agencies, and the pharmaceutical industry. But anthropologist Joao Biehl also tells why this policy, hailed as a model worldwide, has been so difficult to implement among poor Brazilians with HIV/AIDS, who are often stigmatized as noncompliant or untreatable, becoming invisible to the public. More broadly, Biehl examines the political economy of pharmaceutical that lies behind large scale treatment rollouts, revealing the possibilities and inequalities that come with a magic bullet approach to health care."--Jacket.